The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials Group

Precision medicine in oncology poses unique challenges to the generation of clinical and economic evidence used for cost-effectiveness analyses that can inform health technology assessment. The conduct of randomized controlled trials for biomarker-specific therapies targeted towards small population...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Kelvin K. W., Cheung, Matthew C., Regier, Dean A., Hay, Annette, Louie, Alexander V., Cheung, Winson Y., Tarride, Jean-Eric, Udayakumar, Suji, Mittmann, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482104/
https://www.ncbi.nlm.nih.gov/pubmed/34590616
http://dx.doi.org/10.3390/curroncol28050311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482104/
https://www.ncbi.nlm.nih.gov/pubmed/34590616
http://dx.doi.org/10.3390/curroncol28050311

Ejemplares similares